Hi Teddy, interested in your thoughts on Stratagraft, if you're happy to share. From what I can see it was purchased in 2016 (recent?) for between $70-$100m (lower than AVH) and one reason was that they wanted the tech and scientists. A bit of a different paradigm than AVH, regardless of product being in the same market. Also, as far as I can see Stratagraft do not have FDA approval, which is mooted for 2020. Does AVH have first mover advantage?Just want to make sure I get the facts right. Thanks.
Businesswire, page-30
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.84 |
Change
-0.120(3.03%) |
Mkt cap ! $268.3M | |||
| Open | High | Low | Value | Volume |
| $3.94 | $3.94 | $3.76 | $511.0K | 134.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $3.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.84 | 11883 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |